Skip to main content
. 2016 Jun 17;13(6):601. doi: 10.3390/ijerph13060601

Table 3.

Association of the MTHFR C677T polymorphism with risk of essential hypertension.

MTHFR C677T Hypertension, n (%) Normotensive, n (%) Crude OR
(95% CI)
p-Value Adjusted OR (95% CI) p-Value
Codominant
CC 37 (17.29) 119 (24.09) 1.0 (reference) 1.0 (reference)
CT 102 (47.66) 234 (47.37) 1.40 (0.91–2.17) 0.129 1.53 (0.96–2.45) 0.075
TT 75 (35.05) 141 (28.54) 1.71 (1.08–2.72) 0.023 1.81 (1.10–2.98) 0.020
Dominant
CC 37 (17.29) 119 (24.09) 1.0 (reference) 1.0 (reference)
CT + TT 177 (82.71) 375 (75.91) 1.52 (1.01–2.29) 0.046 1.64 (1.05–2.55) 0.029
Recessive
CC + CT 139 (64.95) 353 (71.46) 1.0 (reference) 1.0 (reference)
TT 75 (35.05) 141 (28.54) 1.35 (0.96–1.90) 0.085 1.34 (0.93–1.94) 0.120
Allele
C 176 (41.12) 472 (47.77) 1.0 (reference)
T 252 (58.88) 516 (52.23) 1.31 (1.04–1.65) 0.021

Abbreviations: MTHFR, methylenetetrahydrofolate reductase; OR, odds ratio; CI, confidence interval. Adjusted OR: adjusted for age, gender, BMI, smoking and drinking status. p-Value < 0.05 was considered statistically significant.